MedPearls
Clinical Tools
Emergency Medicine · Sepsis 2026
Sepsis Algorithm 2026
SSC 2026
⚠️ Open in Safari (iOS) or Chrome (Android) for full functionality.
📘 Based on 2026 Surviving Sepsis Campaign International Guidelines (SCCM/ESICM) + EMS Protocols
🚑
Pre-Hospital / EMS

EMS Sepsis Protocol

Field recognition · SIRS criteria · Prehospital treatment · 2026 SSC prehospital recommendations
EMS
Time is Life — Sepsis is a time-dependent emergency
  • Use a standard sepsis screening tool in ambulances/flight 2026 NEW
  • Consider giving antibiotics en route if in-hospital evaluation is > 60 minutes away and patient has likely septic shock 2026 NEW
  • Consider a "Code Sepsis" / Sepsis Huddle protocol on arrival 2026 NEW
Suspected Infection — Consider Appropriate PPE & Infection Control
  • Age (common in elderly and very young)
  • Presence and duration of fever
  • Previously documented infection or illness (UTI, pneumonia, meningitis, encephalitis, cellulitis, abscess)
  • Recent surgery or invasive procedure
  • Immunocompromised (transplant, HIV, diabetes, cancer)
  • Bedridden or immobile patients
  • Prosthetic or indwelling devices
  • Immunization status
  • Hyper or hypothermia
  • Rash and/or excessive bruising
  • Chills · Myalgia (muscle aches)
  • Markedly decreased urine output
  • Altered mentation
  • Delayed capillary refill
  • Elevated blood glucose (unless diabetic)
  • Cardiogenic shock · Hypovolemic shock · Dehydration
  • Hyperthyroidism · Medication/drug interaction
  • Non-septic infection · Allergic reaction/anaphylaxis
  • Toxicological emergency
SIRS Criteria — any of the following:
  • SBP < 90 mmHg
  • Heart rate > 90/min
  • Respiratory Rate > 20/min
  • GCS < 15
  • Temperature ≥ 100.4°F (38°C) or ≤ 96.0°F (35.6°C)
✗ NO — SIRS Not Met
Exit to appropriate protocol — continue monitoring
✓ SIRS Criteria Met — Initiate Sepsis Protocol
💧
IV Fluid Resuscitation
  • Normal Saline 500 mL bolus — then reassess SIRS criteria and re-examine
  • Repeat 500 mL boluses to maximum 2 litres as long as any SIRS criteria present
  • STOP if concern for fluid overload (known CHF, ESRD on dialysis, signs of pulmonary oedema)
  • Aggressive IV fluid is the most important prehospital treatment for sepsis
✓ EtCO₂ < 26 — Declare Sepsis Alert
📢
Declare Sepsis Alert during radio call-in to destination hospital
  • EtCO₂ levels are correlated with lactate levels — a useful marker of hypoperfusion
✗ EtCO₂ ≥ 26
Continue monitoring — reassess frequently
  • EtCO₂ may normalize with fluid resuscitation
  • Elevated serum lactate often precedes hypotension
⚠ Refractory Hypotension — Vasopressor
💉
Norepinephrine IV Infusion
  • 1–10 mcg/min IV infusion titrated to SBP > 90 mmHg
  • Start peripherally — do not delay for central access 2026
✓ Responding to Fluids
Continue monitoring en route
  • Continue reassessing vital signs
  • Notify destination hospital
🏥
Notify Destination per usual procedures or Contact Medical Control
  • Attempt to identify source of infection (skin, respiratory, urinary) — relay to ED
  • DIC is an ominous late manifestation — frank extensive bruising, bleeding from multiple sites
  • Avoid excessive tidal volumes if ventilating — CPAP airway pressure limited to 5 cmH₂O
  • Early recognition allows attentive care and early antibiotics — early is everything
  • Aggressive IV fluids are the most important prehospital treatment
  • Septic patients are especially susceptible to traumatic lung injury and ARDS — avoid excessive tidal volumes
  • Elevated serum lactate often becomes elevated prior to onset of hypotension
  • Disseminated Intravascular Coagulation (DIC) is an ominous, late-stage manifestation — frank extensive bruising, bleeding from multiple sites, tissue death
  • 2026 SSC: Use standard sepsis screening tool in ambulance/flight NEW
  • 2026 SSC: Give antibiotics en route if hospital arrival > 60 min and likely septic shock NEW
  • 2026 SSC: Out-of-hospital approach should store baseline blood samples for rapid analysis at hospital admission NEW
MedPearls
📖
2026 SSC Definitions

Sepsis Definitions & Criteria

Diagnostic criteria · SOFA · Septic shock · Biomarkers
Definitions
2026 Key Change — Clinical Diagnosis NEW
  • Sepsis is a clinical diagnosis and should not be ruled in or out by any single biomarker
  • qSOFA is demoted — poor sensitivity; use NEWS, NEWS2, MEWS, or SIRS instead STRONG REC
  • Phoenix criteria (2024) incorporated alongside older 2005 definitions for paediatrics
Sepsis: Life-threatening organ dysfunction caused by a dysregulated host response to infection (Sepsis-3, 2016)

Practical trigger: Suspected infection + SOFA score ≥ 2

General Variables (infection + any of)
  • Fever (> 38.3°C) or Hypothermia (core temp < 36°C)
  • Heart rate > 90/min or > 2 SD above normal for age
  • Tachypnoea
  • Altered mental status
  • Significant oedema or positive fluid balance (> 20 mL/kg over 24h)
  • Hyperglycaemia (plasma glucose > 7.7 mmol/L or 140 mg/dL) in absence of diabetes
Inflammatory Variables
  • Leucocytosis (WBC > 12,000/µL)
  • Leukopenia (WBC < 4,000/µL)
  • Normal WBC with > 10% immature forms
  • CRP > 2 SD above normal · Procalcitonin > 2 SD above normal
Haemodynamic Variables
  • Arterial hypotension (SBP < 90 mmHg, MAP < 70 mmHg, or SBP decrease > 40 mmHg)
Organ Dysfunction Variables
  • Arterial hypoxaemia (PaO₂/FiO₂ < 300)
  • Acute oliguria (urine output < 0.5 mL/kg/hr for ≥ 2 hrs despite adequate resuscitation)
  • Creatinine increase > 44.2 µmol/L (0.5 mg/dL)
  • Coagulation abnormalities (INR > 1.5 or aPTT > 60 s)
  • Ileus (absent bowel sounds)
  • Thrombocytopenia (platelet count < 100,000/µL)
  • Hyperbilirubinaemia (total bilirubin > 70 µmol/L or 4 mg/dL)
Tissue Perfusion Variables
  • Hyperlactataemia (> 1 mmol/L)
  • Decreased capillary refill or mottling
System01234
Respiration PaO₂/FiO₂≥ 400< 400< 300< 200 + vent< 100 + vent
Coagulation Platelets (×10³/µL)≥ 150< 150< 100< 50< 20
Liver Bilirubin (µmol/L)< 2020–3233–101102–204> 204
Cardiovascular MAP≥ 70< 70Dopa ≤ 5 or DobuDopa 5.1–15 or Norepi/Epi ≤ 0.1Dopa > 15 or Norepi/Epi > 0.1
CNS GCS1513–1410–126–9< 6
Renal Creatinine (µmol/L)< 110110–170171–299300–440 or UO < 500 mL/d> 440 or UO < 200 mL/d
Sepsis = SOFA score ≥ 2 with suspected infection. Each organ system scored 0–4.
🚨
Septic Shock = Sepsis + ALL of:
  • Vasopressor requirement to maintain MAP ≥ 65 mmHg
  • Serum lactate > 2 mmol/L
  • Despite adequate fluid resuscitation

Practical field definition: Sepsis-induced hypotension persisting despite adequate fluid resuscitation

OR: MAP < 65 mmHg OR lactate ≥ 4 mmol/L
2026 SSC: Recommended Screening Tools STRONG
  • NEWS (National Early Warning Score)
  • NEWS2
  • MEWS (Modified Early Warning Score)
  • SIRS criteria
⚠ qSOFA — DEMOTED 2026 CHANGE
  • qSOFA has poor sensitivity for sepsis as a single screening tool
  • No longer recommended as primary screening — use NEWS/NEWS2/MEWS/SIRS instead
  • qSOFA (quick SOFA): RR ≥ 22, altered mentation, SBP ≤ 100 — still useful for clinical awareness but not recommended as sole screen

Biomarkers — 2026 Position
  • Sepsis is a clinical diagnosis — no single biomarker rules in or out
  • Lactate: measure and remeasure if > 2 mmol/L — strong recommendation
  • Procalcitonin: can guide de-escalation but not diagnostic alone
  • Novel rapid host-response diagnostics: insufficient evidence to recommend
The Phoenix Sepsis Score (2024) is now incorporated alongside older 2005 paediatric definitions. The guidelines do not mandate a single diagnostic framework — both may be used based on institutional resources.

Phoenix Sepsis Criteria (simplified)
  • Suspected infection + Phoenix Sepsis Score ≥ 2 points
  • Scores organ dysfunction across: Respiratory, Cardiovascular, CNS, Coagulation systems
  • Septic shock = Phoenix cardiovascular score ≥ 1
Previous 2005 Criteria (still valid)
  • Sepsis = SIRS + suspected/confirmed infection
  • Severe sepsis = Sepsis + organ dysfunction or tissue hypoperfusion
  • Septic shock = Sepsis + cardiovascular dysfunction despite ≥ 40 mL/kg fluid bolus in 1 hour
MedPearls
👨
2026 SSC Adult Guidelines

Adult Sepsis Algorithm

Hour-1 bundle · Resuscitation · Antimicrobials · Respiratory support
Adult
Suspected Infection + SOFA ≥ 2 — SepsisUse NEWS / NEWS2 / MEWS / SIRS for screening (qSOFA demoted — 2026)
Hour-1 Bundle — Start ALL within 1 hour 2026 SSC
  • 1. Measure lactate — remeasure if initial > 2 mmol/L
  • 2. Obtain blood cultures before antibiotics (2 sets, 10 mL each, aerobic + anaerobic)
  • 3. Administer broad-spectrum antibiotics (within 1 hour for septic shock; up to 3 hours for possible sepsis without shock)
  • 4. Administer 30 mL/kg crystalloid IV for hypotension or lactate ≥ 4 mmol/L
  • 5. Apply vasopressors if hypotensive during/after fluids to maintain MAP ≥ 65 mmHg
  • Monitor, support ABCs — insert urinary catheter and monitor urine output
  • Check vital signs: BP, MAP, PR, RR, SpO₂, ToC, RBS, Serum lactate
  • Start Oxygen IF SpO₂ < 94% — maintain SpO₂ ≥ 94%
  • Establish IV access — FBC, MPS, UEC, ABG, Serum lactate
  • Obtain 2 sets blood cultures (10 mL each, aerobic + anaerobic) from different sites before antibiotics
  • Brief, targeted history and physical exam
  • CXR · Urinalysis + MCS
  • Give antipyretic if indicated: Paracetamol 1g IV
  • Consider: echocardiogram, imaging for source
2026 New — Respiratory Assessment
  • High-flow nasal cannula (HFNC) suggested over conventional O₂ and NIV for hypoxaemic respiratory failure NEW
  • Trial of awake proning suggested for non-intubated patients NEW
  • Note: pulse oximetry may overestimate oxygenation in patients with darker skin tones and in shock NEW
Timing
  • Septic shock or probable/definite sepsis: within 1 hour STRONG
  • Possible sepsis without shock: time-limited 3-hour assessment window
Empiric Antibiotics (Severe Sepsis/Septic Shock)
  • Ceftriaxone 2g IV stat — community-acquired general sepsis
  • Imipenem 500 mg IV infusion over 3 hours then QID — probable neutropenic patients or hospital-acquired infection in last 3 months
  • Meropenem 1g IV infusion over 3 hours then TDS — possible CNS infection
  • Full loading dose even if decreased GFR suspected
2026 New — Extended Infusion STRONGLY REC NEW
  • Prolonged (extended/continuous) infusion of beta-lactams now strongly recommended over bolus dosing
  • Upgraded to high-certainty evidence following BLING III trial
De-escalation
  • Strong recommendation: de-escalate once cultures and susceptibilities available STRONG
  • Tailor empiric MDR and anaerobic coverage to risk factors — not routine NEW
  • Selective digestive decontamination (SDD) conditionally suggested for ventilated patients in low-resistance settings NEW
💧
Crystalloid Resuscitation
  • 30 mL/kg IV crystalloid within 3 hours of identification STRONG
  • Use ideal/adjusted body weight in obese patients — not actual weight 2026 NEW
  • Caution in low-resource settings 2026 NEW
  • More rapid and greater amounts may be needed in some patients
Fluid Approach
  • Liberal vs restrictive fluid approach: equivalent — either acceptable 2026
  • Use dynamic measures to guide resuscitation (pulse pressure variation, fluid responsiveness assessment)
  • Serial lactate and capillary refill time endorsed for resuscitation guidance NEW
  • Active fluid removal suggested after acute resuscitation phase NEW
Monitoring
  • Repeat vital signs: BP, MAP, PR, RR, SpO₂, ToC, serum lactate
  • Urine output (< 0.5 mL/kg/h = concern)
  • Diuresis < 0.5 mL/kg/h · Lactate · SvO₂ · ΔPCO₂
  • Capillary refill time/skin · Mental status · Oxygenation
  • 3P: MAP/SAP/DAP · POCUS where available NEW
✓ Haemodynamically Stable
  • Assess continuously: vital signs, diuresis, lactate, capillary refill, mental status, oxygenation
  • Adjust antibiotic therapy according to initial microbiology and expert consultation
  • Optimize antimicrobial doses — consider duration of therapy
  • Remove intravascular access devices that could be possible sources after other IV access established
  • Register all interventions and clinical variables
If NO current indication for admission
  • Clinically stable with NO signs of severe sepsis or septic shock
  • Identify source of infection — if amenable to oral antibiotics, initiate and consider discharge with follow-up
✗ SHOCK — Vasopressors + ICU
Conditionally Suggested — 2026
  • IV Corticosteroids for septic shock — now conditionally suggested (shift toward favoring) UPDATED
  • Active fluid removal after acute resuscitation phase NEW
  • HFNC over conventional O₂ for hypoxaemic respiratory failure NEW
  • Awake proning for non-intubated patients NEW
Suggest AGAINST — 2026
  • Antipyretics for outcome improvement NEW
  • Probiotics NEW
  • Vitamin D NEW
  • Vitamin C (maintained against) REVISITED
  • IVIG (maintained against)
  • Blood purification techniques (maintained against)
  • Routine beta-blockers NEW
  • XueBiJing (outside approved jurisdictions) NEW
Insufficient Evidence — No Recommendation
  • Methylene blue · Midodrine
New 2026 Post-Discharge Recommendations NEW
  • Offer post-critical-illness follow-up services
  • Physical rehabilitation for patients ventilated > 48 hours
  • Mental health support after discharge
  • Advance directives discussion
  • Time-limited trials of critical care
  • Post-discharge care coordination
MedPearls
👶
2026 SSC Paediatric Guidelines

Paediatric Sepsis Algorithm

61 statements · 5 strong recommendations · Phoenix criteria 2024
Paediatric
📘 2026 SSC Paediatric Guidelines: 61 statements — 5 strong, 24 conditional, 10 good practice. Only 3 based on high/moderate certainty evidence. Phoenix criteria (2024) incorporated alongside 2005 definitions.
Suspected Paediatric SepsisSuspected infection + Phoenix Sepsis Score ≥ 2 OR 2005 SIRS-based criteria
2026 Change — Systematic Screening REVERSED
  • The 2020 weak recommendation for systematic screening was withdrawn
  • Insufficient evidence (including a new RCT) to recommend systematic sepsis screening
  • Clinical recognition and bedside assessment remain primary
POCUS — New 2026 Recommendation NEW
  • POCUS (cardiac and lung) is newly suggested to guide resuscitation where training/resources allow
Lactate — Strengthened to Strong STRONG UPGRADED
  • Measure blood lactate as part of initial evaluation — now a strong recommendation (was previously non-recommendation)
Performance Improvement Programs STRONG
  • Performance improvement programs with standard operating procedures are now strongly recommended
  • Suspected septic shock: within 1 hour
  • Probable sepsis without shock: within 3 hours (after time-limited rapid investigation)
  • Obtain blood cultures before antibiotics whenever possible
De-escalation — 2026 NEW
  • Procalcitonin is suggested against for routine antibiotic de-escalation where good stewardship already exists (moderate certainty)
  • Infectious diseases consultation suggested for documented bloodstream infections NEW
✓ ICU Available
💧
Fluid Bolus Protocol
  • Up to 40–60 mL/kg in boluses of 10–20 mL/kg each
  • Reassess after every bolus — stop if fluid overload develops
  • Crystalloid (NS or Ringer's Lactate)
✗ No ICU — Without Hypotension
🚫
Do NOT give fluid boluses STRONG · HIGH CERTAINTY
  • In settings without intensive care and without hypotension — do not give fluid boluses
  • One of the few high-quality evidence recommendations in paediatric sepsis
  • Epinephrine (adrenaline) or Norepinephrine — both acceptable first-line agents
  • Start peripherally rather than delaying for central access
  • Choice between epinephrine vs norepinephrine: insufficient evidence — either acceptable
  • Timing of vasoactives relative to fluid volume: insufficient evidence
  • Angiotensin II, Methylene blue: insufficient evidence
Doses
  • Norepinephrine: titrate to MAP ≥ 65 mmHg (or age-appropriate MAP)
  • Epinephrine (adrenaline): 0.05–0.3 µg/kg/min IV infusion
  • Start with lowest effective dose — titrate to response
🫁
Conservative O₂ Targets for Intubated Children MODERATE CERTAINTY
  • SpO₂ 88–92% over liberal (>94%) for intubated children post-resuscitation
  • Based on OxyPICU trial — one of the rare moderate-certainty paediatric recommendations 2026 NEW
  • During resuscitation: maintain SpO₂ ≥ 94%
🔄
High-Volume Haemofiltration > 35 mL/kg/hr now PREFERRED over standard-volume
  • Full reversal of the 2020 position — previously standard volume was recommended
  • Plasma exchange for TAMOF: insufficient evidence
  • Extracorporeal blood purification: insufficient evidence
  • Early rehabilitation bundles during acute illness are newly recommended
  • Post-sepsis follow-up: assess risk factors, educate families, evaluate for long-term sequelae after discharge
  • Fever management: 2020 stance allowing antipyretics or permissive fever was downgraded to "insufficient evidence"
Paediatric Sepsis — Where Evidence Remains Insufficient
  • Choice between epinephrine vs norepinephrine first-line
  • Timing of vasoactives relative to fluid volume
  • Angiotensin II · Methylene blue · Sodium bicarbonate
  • Extracorporeal blood purification · Plasma exchange for TAMOF
  • Immune stimulants/immunosuppressants for specific subphenotypes
  • Fever management (antipyretics vs permissive fever)
  • Systematic sepsis screening
MedPearls
Adult — Severe Sepsis / Septic Shock

Septic Shock Algorithm

Vasopressors · MAP targets · Dobutamine · Hydrocortisone · ICU
Septic Shock
Septic Shock — MAP < 65 mmHg despite fluids OR Lactate ≥ 4 mmol/L
🚨
Immediate — Consult Physician & ICU
  • Consult a Physician immediately
  • Start peripheral vasopressors if MAP < 65 mmHg — do not delay for central access 2026
  • All patients requiring vasopressors must have arterial catheter placed as soon as resources available
  • Admit HDU/ICU
  • Anticipate echocardiogram and central IV access
  • Follow protocolised early sepsis care bundles
  • Standard target: MAP ≥ 65 mmHg — maintained STRONG
  • Patients aged ≥ 65: consider lower MAP range of 60–65 mmHg — conditional recommendation based on 65 trial 2026 NEW
  • Permissive hypotension in older patients may reduce fluid load and vasopressor burden
  • Prioritise MAP ≥ 65 mmHg to preserve tissue perfusion
1st Line — Norepinephrine FIRST LINE
Start: 0.01 mcg/kg/min IV Titrate every 3–5 min to achieve MAP ≥ 65 mmHg Typical range: 0.1–1.3 µg/kg/min Start peripherally — do not delay for central access
If relative bradycardia with low-risk for arrhythmias — consider dopamine as alternative
2nd Line — Add Vasopressin (escalating doses)
0.03–0.04 units/min IV infusion
Add when norepinephrine dose escalating. May allow norepinephrine dose reduction.
3rd Line — Epinephrine (Adrenaline)
Adult: 0.05–0.3 µg/kg/min IV infusion Paeds: 0.05–0.3 µg/kg/min IV infusion
Add or substitute when norepinephrine + vasopressin insufficient
Concomitant Cardiac Dysfunction
Norepinephrine OR Epinephrine — both acceptable
New 2026 recommendation — either agent acceptable for cardiac dysfunction in septic shock
Dobutamine (Adults)
Up to 20 µg/kg/min IV infusion (+ vasopressor if in use)
Indications: a) Myocardial dysfunction as suggested by elevated cardiac filling pressures and low cardiac output; OR b) Ongoing signs of hypoperfusion despite adequate intravascular volume and adequate MAP
💊
Hydrocortisone — Conditionally Suggested for Septic Shock SHIFT TOWARD FAVORING
  • IV Hydrocortisone 200 mg IV bolus — then continue infusion
  • Indicated when haemodynamic stability NOT achieved with adequate fluid resuscitation and vasopressor therapy
  • 2026: Shifted from uncertain to conditionally suggesting steroids in septic shock
✓ Haemodynamic Stability Achieved
🟢
Admit HDU/ICU
  • Continue monitoring — de-escalate antibiotics when cultures available
  • Plan active fluid removal after acute phase 2026 NEW
  • Consider post-sepsis recovery planning
✗ Hypoperfusion Persists
🔄
Escalate — Dobutamine + Intensivist Review
  • Give Dobutamine infusion up to 20 µg/kg/min + vasopressor if in use
  • Reassess continuously — rule out additional causes of shock
  • Assess valid dynamic predictive variables of volume response
  • Consider fluid challenge if fluid responsive
  • Intensivist consultation for ICU admission
🏥
Admit HDU/ICU — connected to monitoring
MedPearls
💊
Drug Reference

Medications

Antibiotics · Vasopressors · Steroids · Doses · 2026 SSC recommendations
Medications
Ceftriaxone (3rd generation cephalosporin)
2g IV stat
Community-acquired general sepsis. Full loading dose even if decreased GFR suspected.
Imipenem (carbapenem)
500 mg IV infusion over 3 hours then QID
For probable neutropenic patients or hospital-acquired infection (admitted in last 3 months). Extended infusion per 2026 SSC strong recommendation.
Meropenem (carbapenem)
1g IV infusion over 3 hours then TDS
Possible CNS infections. Better CNS penetration than imipenem.
2026 SSC — Extended/Continuous Beta-Lactam Infusion STRONG · HIGH CERTAINTY NEW
  • Prolonged (extended/continuous) infusion of beta-lactams now strongly recommended over bolus dosing
  • Based on BLING III trial — upgraded to high-certainty evidence
  • Applies to all beta-lactam antibiotics including ceftriaxone, imipenem, meropenem, piperacillin-tazobactam
Norepinephrine (Noradrenaline)
Adults: start 0.01 mcg/kg/min IV Titrate every 3–5 min Range: 0.1–1.3 µg/kg/min EMS: 1–10 mcg/min IV infusion to SBP > 90
Start peripherally — do not delay for central access (2026 SSC). First-line for septic shock. Titrate to MAP ≥ 65 mmHg.
Adrenaline / Epinephrine
Adults: 0.05–0.3 µg/kg/min IV infusion Paeds: 0.05–0.3 µg/kg/min IV infusion
Add or substitute when norepinephrine insufficient. Also acceptable first-line in paediatrics (equal to norepinephrine per 2026 SSC — insufficient evidence for preference).
Vasopressin
0.03–0.04 units/min IV infusion
Add when escalating norepinephrine dose. May allow norepinephrine dose reduction.
Dopamine
2–20 µg/kg/min IV infusion
Only if relative bradycardia with low-risk for arrhythmias present. Norepinephrine preferred otherwise.
Dobutamine
Up to 20 µg/kg/min IV infusion (+ vasopressor if in use)
Indications: myocardial dysfunction with elevated cardiac filling pressures and low cardiac output; OR ongoing hypoperfusion despite adequate volume and MAP.
Hydrocortisone
200 mg IV bolus — then continuous infusion
2026 SSC: conditionally suggested for septic shock (shift toward favoring). Use when haemodynamic stability not achieved with adequate fluids and vasopressors.
Paracetamol
1g IV if indicated
Note: 2026 SSC suggests against antipyretics specifically for outcome improvement in sepsis — use for patient comfort only. Insufficient evidence in paediatrics.
Therapies to AVOID in Sepsis — 2026 SSC
  • Vitamin C — suggest against
  • IVIG — suggest against
  • Blood purification techniques — suggest against
  • Probiotics — suggest against (new 2026)
  • Vitamin D — suggest against (new 2026)
  • Antipyretics specifically for outcome improvement — suggest against (new 2026)
  • Routine beta-blockers — suggest against (new 2026)
  • XueBiJing outside approved jurisdictions — suggest against (new 2026)
MedPearls
📋
Quick Reference

Reference Guide

Bundle comparison · Monitoring targets · 2026 biggest changes · Scoring
Reference
ChangeDirectionStrength
qSOFA demoted as screening toolUse NEWS/NEWS2/MEWS/SIRS insteadStrong
Beta-lactam extended infusionNow strongly recommended (BLING III)Strong · High certainty
Corticosteroids in septic shockShift toward favoring (conditional)Conditional
MAP target in elderly (≥65 yrs)Lower range 60–65 mmHg acceptableConditional
Prehospital antibioticsGive en route if hospital >60 min awayNew recommendation
HFNC for respiratory failureSuggested over conventional O₂ and NIVNew
Awake proningSuggested for non-intubated patientsNew
SDD in low-resistance settingsConditionally suggestedNew
Active fluid removal post-resuscitationConditionally suggestedNew
Antipyretics for outcome improvementSuggest againstNew · Against
Post-sepsis recovery emphasisNew section: rehab, mental health, follow-upNew GPS
Paeds: lactate measurementUpgraded to strong recommendationStrong (upgraded)
Paeds: O₂ target intubatedConservative SpO₂ 88–92% post-resuscitationModerate certainty
Paeds: High-volume haemofiltrationNow preferred >35 mL/kg/hr (reversal)Reversed
Paeds: Systematic screeningWithdrawn — insufficient evidenceWithdrawn
Element2018 Hour-12026 Status
Measure lactateYes — remeasure if >2Retained — Strong
Blood cultures before antibioticsYesRetained — GPS
Broad-spectrum antibioticsWithin 1 hourRetained — Strong (with 3-hr window for possible sepsis)
30 mL/kg crystalloidIf hypotension or lactate ≥4Retained — Strong (weight-adjusted)
Vasopressors for persistent hypotensionYes — MAP ≥65Retained — Strong (peripheral start endorsed)
ScvO₂ ≥70% / CVP ≥8 targetsRemoved in 2016Still removed — outdated
Activated protein CRemoved in 2012Still removed
Quantitative resuscitationRemoved in 2016Still removed
Outdated elements (CVP targets, ScvO2 goals, activated protein C) removed since 2016 and remain removed in 2026.
ParameterTargetNotes
MAP≥ 65 mmHg≥ 60–65 acceptable in elderly ≥65 yrs (2026)
Lactate≤ 2 mmol/LRemeasure if >2; elevated lactate = poor perfusion marker
Urine output≥ 0.5 mL/kg/hInsert urinary catheter
SpO₂ (non-intubated)≥ 94%HFNC preferred if hypoxaemic respiratory failure
SpO₂ (intubated — paeds post-resus)88–92%Conservative target — OxyPICU trial (2026 paeds)
Capillary refill time< 2 secondsEndorsed as resuscitation guide (2026)
Diuresis> 0.5 mL/kg/hReassess continuously
Blood cultures2 sets before antibiotics10 mL each — aerobic + anaerobic
Practices Removed from SSC Guidelines — No Longer Recommended
  • CVP target ≥ 8 mmHg (removed since 2016)
  • ScvO₂ ≥ 70% as fixed resuscitation goal (removed since 2016)
  • Activated protein C / Drotrecogin alfa (removed since 2012)
  • Quantitative resuscitation protocols
  • qSOFA as primary screening tool (demoted 2026)
  • Routine beta-blockers (new 2026 — suggest against)
  • Vitamin C (suggest against — maintained 2026)
  • IVIG (suggest against — maintained 2026)
  • Blood purification (suggest against — maintained 2026)
  • Systematic paediatric sepsis screening (withdrawn 2026)
SOFA — Sepsis Diagnosis (Preferred)
  • Sepsis = Suspected infection + acute SOFA ≥ 2
  • Assess: Respiration, Coagulation, Liver, Cardiovascular, CNS, Renal
qSOFA — Clinical Awareness Only (demoted 2026)
  • RR ≥ 22/min · Altered mentation · SBP ≤ 100 mmHg
  • Score 0–3; ≥ 2 = high risk
  • No longer recommended as primary screening tool — poor sensitivity
NEWS2 — Now Recommended for Screening (2026)
  • Respiratory rate · SpO₂ · Supplemental O₂ · Temperature · Systolic BP · HR · Level of consciousness
  • Score ≥ 5 = urgent review · Score ≥ 7 = emergency
2026 SSC — Health Equity & Low-Resource Settings
  • Attention to low-resource settings and health equity woven into nearly every 2026 recommendation
  • 30 mL/kg fluid bolus: use ideal/adjusted weight in obese patients; caution in low-resource settings
  • Blood cultures: single-site cultures acceptable in low-resource settings
  • Paeds: do NOT give fluid boluses without ICU in low-resource settings without hypotension (strong, high certainty)
  • Pulse oximetry may overestimate oxygenation in patients with darker skin tones and in shock
MedPearls
For educational use only · Based on 2026 SSC Guidelines — verify against current institutional protocols · Not a substitute for clinical judgment · MedPearls Clinical Tools 2026